Stock comparison
REVVITY, INC. is 2.3x more valuable than 10x Genomics, Inc. by market capitalization ($12.74 B vs $5.50 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
RVTY is larger
REVVITY, INC. is 2.3x more valuable than 10x Genomics, Inc. by market capitalization ($12.74 B vs $5.50 B).
Market value leader
RVTY
REVVITY, INC. is 2.3x more valuable than 10x Genomics, Inc. by market capitalization ($12.74 B vs $5.50 B).
Revenue leader
RVTY
TXG: $642.82M vs RVTY: $2.86B.
Profit leader
RVTY
TXG: -$43.50M vs RVTY: $241.20M.
Margin leader
RVTY
TXG: -6.8% vs RVTY: 8.4% net margin.
| Metric | TXG | RVTY |
|---|---|---|
| Market cap | $5.50 B | $12.74 B |
| US-listed rank | #1345 | #815 |
| Revenue (latest FY) | $642.82M | $2.86B |
| Net income (latest FY) | -$43.50M | $241.20M |
| Net margin | -6.8% | 8.4% |
| P/E (trailing FY) | - | 52.8x |
| SEC filings | 652 | 1,745 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
REVVITY, INC. is 2.3x more valuable than 10x Genomics, Inc. by market capitalization ($12.74 B vs $5.50 B).
In their latest fiscal years, 10x Genomics, Inc. reported $642.82M in revenue while REVVITY, INC. reported $2.86B.
Full pages: 10x Genomics, Inc. and REVVITY, INC., or browse the full rankings.